These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1568001)

  • 1. Heparin content of washed red blood cells from the cardiopulmonary bypass circuit.
    Gravlee GP; Hopkins MB; Yetter CR; Buss DH
    J Cardiothorac Vasc Anesth; 1992 Apr; 6(2):140-2. PubMed ID: 1568001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of blood washing and autotransfusion during cardiopulmonary bypass on erythrocyte immune and kidney function].
    Song Y; Li R; Gu XH; Gong XJ; Zhang G; Wu SM; Zhang XQ; Li SX
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2293-6. PubMed ID: 17064580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrifugation of salvaged pump blood is useful in reducing the amount of heparin re-infused into the patient.
    Ean AH; Yan TS; Chan T; James E; Chi OB
    Perfusion; 2001 Jul; 16(4):309-12. PubMed ID: 11486850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of heparin in the residual pump oxygenator blood, reinfused postoperatively after cardiopulmonary bypass.
    Singh G; Gayler M; Wyatt R; Spyt TJ
    Perfusion; 1994; 9(4):271-5. PubMed ID: 7734016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of red cell separation and ultrafiltration on heparin concentration during pediatric cardiac surgery.
    Williams GD; Ramamoorthy C; Totzek FR; Oakes RL
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):840-4. PubMed ID: 9412881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of residual blood autotransfused from cardiopulmonary bypass circuit on clinical outcome after cardiac surgery.
    Sirvinskas E; Lenkutis T; Raliene L; Veikutiene A; Vaskelyte J; Marchertiene I
    Perfusion; 2005 Mar; 20(2):71-5. PubMed ID: 15918443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal heparin adsorption following cardiopulmonary bypass with a heparin removal device--an alternative to protamine.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Zwischenberger JB
    Crit Care Med; 1998 Jun; 26(6):1096-102. PubMed ID: 9635661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin elimination and free hemoglobin following cell separation and washing of autologous blood with Cell Saver 4].
    Kling D; Börner U; von Bormann B; Hempelmann G
    Anasth Intensivther Notfallmed; 1988 Apr; 23(2):88-90. PubMed ID: 3394905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of centrifugal and roller pumps on survival of autologous red cells in cardiopulmonary bypass surgery.
    Valeri CR; MacGregor H; Ragno G; Healey N; Fonger J; Khuri SF
    Perfusion; 2006 Dec; 21(5):291-6. PubMed ID: 17201084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device.
    Boyle G; Kuffel A; Parmar K; Gibson K; Smith M; Grehan A; Hunt BJ; Chambers DJ
    Perfusion; 2019 Jan; 34(1):76-83. PubMed ID: 30067140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
    Arén C; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haemostatic effectiveness of autologous platelet rich plasma sequestered after heparin administration and institution of cardiopulmonary bypass.
    Quigley RL; Perkins JA; Caprini JA; Haney E; Switzer SS; Wallock ME; Hoff WJ; Kuehn BE; Arentzen CE; Alexander JC
    Perfusion; 1995 Mar; 10(2):101-10. PubMed ID: 7647378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit.
    Amand T; Pincemail J; Blaffart F; Larbuisson R; Limet R; Defraigne JO
    Perfusion; 2002 Mar; 17(2):117-23. PubMed ID: 11958302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.